Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for September 30, 2014

September 30, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Acutus Medical pulls in $26M

September 30, 2014 by Alexander Soule

Acutus Medical secured $26.2 million in new funding for its cardiac mapping technology.

Acutus Medical pulls in $26M

Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it's developing to image and map atrial fibrillation hotspots.

Baxter biopharm spinout Baxalta's R&D is Cambridge-bound

September 30, 2014 by Alexander Soule

Baxter International confirmed Cambridge, Mass., as the new R&D hub for Baxalta, the planned spinout of its biopharmaceuticals business.

Baxter biopharm spinout Baxalta's R&D is Cambridge-bound

What to be wary of in the government's new site detailing industry money to docs

September 30, 2014 by MassDevice

The government's new website on drug and device company ties to doctors will be incomplete and may be misleading - for now.

What to be wary of in the government's new site detailing industry money to docs

David Sleight/ProPublica

by Charles Ornstein, ProPublica

This story was co-published with NPR's Shots blog.

'Frotox' maker Myoscience raises $8m

September 30, 2014 by Alexander Soule

Myoscience secures $8.4 million in new funding for its 'frotox' device that applies extreme cold to the skin to temporarily treat pain and smooth wrinkles.

'Frotox' maker Myosure raises $8m

Myoscience said it landed $8.4 million of a hoped-for $11.5 million for a device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles.

FDA releases final recs on legal exemptions for customized medical devices | Regulatory news for the week of September 29, 2014

September 30, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA guides on custom devices; FDA approves Gore's Viabahn for peripheral stent repair; Alcon wins date with FDA panel for AcrySof lens; FDA seeks public input on medtech hacking; ReFlow Medical wins CE Mark for crossing catheters;

FDA guides on custom devices

September 25, 2014 by Alexander Soule

FDA guides on custom devices

Activist investor erupts at Volcano

September 30, 2014 by Alexander Soule

Activist investor fund Engaged Capital ups the pressure on Volcano Corp., scolding it for its $116 million AtheroMed acquisition and missing chances to sell itself at a premium.

Activist investor erupts at Volcano
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp